Scholarly Journals--Published

  • Chitsike, L.; Yuan, C-H.; Roy, A.; Boyle, KE.; Duerksen-Hughes, PJ. A high-content AlphaScreen identifies E6-specific small molecule inhibitors as potential therapeutics for HPV+ head and neck squamous cell carcinomas. Oncotarget202112, 549–561 (04/2021) (link)
  • Rowland, L. K.; Campbell, P. S.; Mavingire, N.; Wooten, J. V.; McLean, M.; Zylstra, D.; Thorne, G.; Daly, D.; Boyle, K. E.; Brantley, E, J. Putative tumor suppressor, cytoglobin, assists aryl hydrocarbon receptor agonist, 5F 203, in conferring apoptosis in MDA-MA-468 cell line.  J. Cell. Biochem.2019120, 6004–6014  (02/2019) (link)
  • Boyle, K. E.; Boger, D. L.; Wroe, A.; Vazquez, M. Duocarmycin SA, a potent antitumor antibiotic, sensitizes glioblastoma cells to proton radiation, Bioorganic and Medicinal Chemistry Letters, 2018, 28 (16), 2688–2692 (09/2018) (link)
  • Chanda, P. B.; Boyle, K. E.; Brody, D. M.; Vyom, S.; Boger, D. L. Synthesis and evaluation of duocarmycin SA analogs incorporating the methyl 1,2,8,8a-tetrahydrocyclopropa-[c]imidazole[4,5-e]indol-4-one-6-carboxylate (CImI) alkylation subunit. Bioorg. Med. Chem. 201624, 4779–4786 (06/2016) (link)
  • Whitby, L. R.; Boyle, K. E.; Cai, L.; Yu, X.; Gochin, M.; Boger, D. L.  Discovery of HIV fusion inhibitors targeting gp41 using a comprehensive α-helix mimetic library. Bioorg. Med. Chem. Lett. 201222, 2861–2865. (09/2012) (link)
  • Lee, T.; Robichaud, A. J.; Boyle, K. E.; Lu, Y.; Robertson, D. W.; Miller, K. J.; Fitzgerald, L. W.; McElroy, J. F.; Largent, B. L.  Novel, highly potent, selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics.  Bioorg. Med. Chem. Lett. 200313, 767–770. (02/2003) (link)